Eutilex Co Ltd

263050

Company Profile

  • Business description

    Eutilex Co Ltd is a Korean that operates in the anti-tumor immunotherapy market. The company develops anti-tumor T cell therapy and antibody therapeutics based on its immunotherapy technology. Its pipeline products include T Cell Therapy (4-1BB CTL), CAR-T, and Antibody.

  • Contact

    Daeryung Technotown 17
    Suite 1401
    Gasan Digital 1-ro 25
    Geumcheon-gu
    Seoul08594
    KOR

    T: +82 234027310

    http://www.eutilex.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    141

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,637.8012.900.15%
CAC 407,789.461.360.02%
DAX 4023,972.8165.38-0.27%
Dow JONES (US)42,101.572.870.01%
FTSE 1008,726.320.310.00%
HKSE23,573.38315.071.35%
NASDAQ19,244.89143.950.75%
Nikkei 22538,432.98710.581.88%
NZX 50 Index12,281.3180.95-0.65%
S&P 5005,913.0224.470.42%
S&P/ASX 2008,409.8012.900.15%
SSE Composite Index3,363.4523.510.70%

Market Movers